Taking lenient stance, NICE backs neuroblastoma drug
Body makes special case due to rarity of the disease
X
Taking lenient stance, NICE backs neuroblastoma drug
https://pharmaphorum.com/news/taking-lenient-stance-nice-backs-neuroblastoma-drug/
EUSA Pharma
NICE asks EUSA pharma to drop price of neuroblastoma drug
NICE calls for price cut before possible CDF funding
EUSA Pharma’s Fotivda approved in EU for kidney cancer
UK pharma gets licence for second cancer drug
